Fidelity SPDR Advertisement
Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

CTIX RSS Feed
Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator BigKahuna, BooDog, KarinCA, noretreat, TOB, starbuxsux
Search This Board:
Last Post: 10/21/2014 3:35:57 PM - Followers: 488 - Board type: Free - Posts Today: 95

Cellceutix Corporation (CTIX) 
 

 

http://cellceutix.com/
 

 
Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
Email:  info@cellceutix.com
 
CIK:  0001355250
 
Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antibiotic applications. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin is currently in a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. In the laboratory Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is planning a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention and treatment of Oral Mucositis. Brilacidin-OM, a defensin mimetic compound, has shown in the laboratory to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol is presently in a bioequivalence crossover clinical trial in Miami, FL. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s key antibiotic, Brilacidin, is in a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Brilacidin has the potential to be a single-dose therapy or a dosing regimen that is shorter than currently marketed antibiotics for multi-drug resistant bacteria (Superbugs). Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.

 

Management:   http://cellceutix.com/team/
 
Ongoing Human Trials:  http://clinicaltrials.gov/ct2/results?term=Cellceutix+Pharmaceuticals&Search=Search
 
Product Pipeline:  http://cellceutix.com/pipeline/
 

 
Recent News and Press Releases: 
http://finance.yahoo.com/q/h?s=CTIX+Headlines

Seeking Alpha focus articles on CTIX: http://seekingalpha.com/symbol/CTIX
 
http://cellceutix.com/category/press-release/
 
SEC Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=Cellceutix+Corp&match=&CIK=ctix&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f
cs@wcsti.com
http://www.westcoaststocktransfer.com/

 
Share Structure:  See SEC filing link above for current share structure
 

Cellceutix IP - Patent Filings:
EPO
http://worldwide.espacenet.com/searchResults?PA=Cellceutix&DB=EPODOC&locale=en_EP&ST=advanced&compact=false
WIPO
http://www.wipo.int/patentscope/search/en/detail.jsf?docId=WO2010135170&recNum=1&docAn=US2010034838&queryString=FP:(Cellceutix)&maxRec=1
USPTO
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=Cellceutix&FIELD1=AS&co1=AND&TERM2=&FIELD2=&d=PG01 


http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,796,275.PN.&OS=PN/8,796,275&RS=PN/8,796,275
 

Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
 
External Links: USPTO, USPTO Assignment, Espacenet


http://www.google.com/patents/US8338454

http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=6&f=G&l=50&co1=AND&d=PG01&s1=Cellceutix.AS.&OS=AN/Cellceutix&RS=AN/Cellceutix

 
Investor Relations:  info@cellceutix.com
 


 
 


 
 
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTIX
Current Price
Volume:
Bid Ask Day's Range
Wiki
CTIX News: ALTITRADE PARTNERS™ SAYS A KEY-REVERSAL DAY COULD HAPPEN THIS WEEK 10/14/2014 06:00:00 AM
CTIX News: Current Report Filing (8-k) 09/24/2014 03:48:22 PM
CTIX News: Annual Report (10-k) 09/15/2014 01:50:04 PM
CTIX News: Statement of Ownership (sc 13g) 09/04/2014 04:14:23 PM
CTIX News: Current Report Filing (8-k) 09/02/2014 06:29:26 AM
PostSubject
#73892  Sticky Note My thesis is to hold all CTIX shares TOB 10/16/14 03:11:33 PM
#73082  Sticky Note Patrick Cox interviews Cellceutix Executives Dr. Menon & sox040713 10/09/14 04:20:59 PM
#69978  Sticky Note Cellceutix to President Obama: We Have The Tools CHM_760 09/19/14 07:22:18 AM
#69616  Sticky Note Based on the stock movement, I think that BioHedge 09/16/14 06:47:44 PM
#67831  Sticky Note $CTIX News, SEC filings, FDA trials, misc., and KarinCA 09/03/14 06:13:02 PM
#57289  Sticky Note Cellceutix Initiates Clinical Trial of Prurisol as New starbuxsux 03/25/14 09:02:21 AM
#74366   Sure, that could be. Could be Aspire. Clearly frrol 10/21/14 03:59:23 PM
#74365   There is no "battle". There are people buying frrol 10/21/14 03:55:44 PM
#74364   It seems to me like someone has a waikikian 10/21/14 03:55:18 PM
#74363   3.08 here we come Ringrock 10/21/14 03:54:32 PM
#74362   Trying to close over $3 for just the TheMonolith 10/21/14 03:35:57 PM
#74361   Thought something catastrophic happened....volume stalled and no one Spebenz 10/21/14 03:29:35 PM
#74360   Good idea,.. something easy for YOU to use. cabel 10/21/14 03:25:30 PM
#74359   I'm going to start by getting her a ctix 10/21/14 03:20:07 PM
#74358   Everyone is out window shopping for what they cabel 10/21/14 03:17:41 PM
#74357   Hello?? Spebenz 10/21/14 03:13:17 PM
#74356   Volume has tappered off,... cabel 10/21/14 01:51:55 PM
#74354   The best way to catch some good PR jok 10/21/14 01:34:47 PM
#74353   timely... and remember the day it was posted... Ringrock 10/21/14 01:23:59 PM
#74352   Thanks KMBJN, I try and learn at F1ash 10/21/14 01:21:11 PM
#74351   Thanks to you and BK for the replies. F1ash 10/21/14 01:14:07 PM
#74350   Quite the battle going on in the $3 range. waikikian 10/21/14 01:13:22 PM
#74349   How about this afternoon. TheMonolith 10/21/14 01:12:32 PM
#74348   Regarding a breakout...Uncle! Maybe tomorrow. TheDane 10/21/14 01:11:33 PM
#74347   The black-box warning for Prurisol would be for KMBJN 10/21/14 01:04:58 PM
#74346   You're DoubleJ23. I for one don't mind that ShinSekai 10/21/14 01:04:01 PM
#74345   Lunch must be over... Say good bye to Ringrock 10/21/14 01:02:56 PM
#74344   CTIX specifically mentions the possibility of a box DoubleJ23 10/21/14 12:58:56 PM
#74343   Dear fence sitters, we are willing to buy monkeyplay1 10/21/14 12:10:53 PM
#74341   Yes, as noretreat mentioned, it is really exceptional TOB 10/21/14 12:00:10 PM
#74340   Fellow longs, hold tight of your CTIX stocks. monkeyplay1 10/21/14 11:55:03 AM
#74339   2 bucks for the Nyse Mkt and 4 Apparition 10/21/14 11:54:28 AM
#74338   You know a lot more about this than Spebenz 10/21/14 11:53:09 AM
#74337   Volume is already above average for this coil, TOB 10/21/14 11:52:58 AM
#74336   Thanks for that. I think that the last smilingra 10/21/14 11:51:46 AM
#74335   I would say volume is pretty exceptional today. hazelhurst 10/21/14 11:48:32 AM
#74334   MM's just go with the flow. They can't TOB 10/21/14 11:47:18 AM
#74333   close... 3.08 Ringrock 10/21/14 11:43:20 AM
#74332   if the buying pressure continues we will BooDog 10/21/14 11:42:35 AM
#74331   CTIX Daily chart, mid-day look. TOB 10/21/14 11:38:04 AM
#74330   I hope you are right. I feel Spebenz 10/21/14 11:33:12 AM
#74329   No worries. The volume is not exceptional and TOB 10/21/14 11:28:39 AM
#74328   Excellent volume. Volume before price. I think it TheDane 10/21/14 11:26:09 AM
#74327   What happened with the 50k block at 3.01? faraifarai 10/21/14 11:15:53 AM
#74326   It's going to hover around $3.05 all day, Spebenz 10/21/14 11:14:15 AM
#74325   " there was no recurrence of psoriasis in F1ash 10/21/14 11:13:45 AM
#74324   I want my 50 shares at 2.93. Someone faraifarai 10/21/14 11:08:42 AM
#74323   Good volume today,... I say we close at $3.06! cabel 10/21/14 11:04:21 AM
#74322   CTIX 3.05: Bid 3.04 X Ask 3.05 TOB 10/21/14 10:45:28 AM
#74321   I have a really good feeling about Prurisol. thefamilyman 10/21/14 10:43:42 AM
#74320   Prurisol™ Autoimmune/Dermatology Studies TOB 10/21/14 10:41:32 AM
#74319   New HOD/HOY contest. I think we hit new TheDane 10/21/14 10:40:06 AM
#74318   Leo is choreographing the timing of the events Tails 10/21/14 10:33:51 AM
#74317   Yes, it did. But I get the idea. TheDane 10/21/14 10:33:00 AM
#74316   BK, In your photo at bottom, is that Emperor someconcerns 10/21/14 10:29:28 AM
#74315   the info is in a recent PR. govorchin 10/21/14 10:28:42 AM
PostSubject